Neratinib Combined With Fulvestrant and Eribulin in the Treatment ofHR+/HER2+ Advanced Breast Cancer

NCT07333937 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Brest Cancer

Interventions

DRUG: Neratinib Combined with Fulvestrant and Eribulin

Sponsor

Xijing Hospital